SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Novartis
NVS 126.33-0.2%10:13 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Eric Dickson who wrote (49)8/19/1997 8:24:00 AM
From: Chuck. Edwards   of 296
 
Novartis was strongly recommended by a Manhattan hedge fund, Rudman Partners, in this week's Barrons. At the then-price of 75-76, they thought the stock has a "one-third" upside within 12 months, an implicit target of 100. They termed the company's pipeline "extraordinarily rich."

Well, at 72, the stock is even cheaper. I'm thinking of buying more (I was in at 58), Anyone out there have any opnion? Any TA perspective? Thanks in advance for any info!

Chuck Edwards
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext